477 related articles for article (PubMed ID: 19273222)
1. Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.
Mulder J; Karpen SJ; Tietge UJ; Kuipers F
Front Biosci (Landmark Ed); 2009 Jan; 14(7):2599-630. PubMed ID: 19273222
[TBL] [Abstract][Full Text] [Related]
2. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease.
Claudel T; Zollner G; Wagner M; Trauner M
Biochim Biophys Acta; 2011 Aug; 1812(8):867-78. PubMed ID: 21194565
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.
Arrese M; Karpen SJ
Clin Pharmacol Ther; 2010 Apr; 87(4):473-8. PubMed ID: 20200515
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in the pathophysiology of cholestasis.
Hutchins GF; Gollan JL
Clin Liver Dis; 2004 Feb; 8(1):1-26, v. PubMed ID: 15062190
[TBL] [Abstract][Full Text] [Related]
5. The role of inflammation in cholestasis: clinical and basic aspects.
Kosters A; Karpen SJ
Semin Liver Dis; 2010 May; 30(2):186-94. PubMed ID: 20422500
[TBL] [Abstract][Full Text] [Related]
6. [Role of PXR and CAR in cholestasis].
Suh JI
Korean J Hepatol; 2006 Mar; 12(1):5-15. PubMed ID: 16565602
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.
Wagner M; Trauner M
Ann Hepatol; 2005; 4(2):77-99. PubMed ID: 16010241
[TBL] [Abstract][Full Text] [Related]
8. FXR and PXR: potential therapeutic targets in cholestasis.
Jonker JW; Liddle C; Downes M
J Steroid Biochem Mol Biol; 2012 Jul; 130(3-5):147-58. PubMed ID: 21801835
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets for the treatment of fibrosing cholangiopathies.
Maillette de Buy Wenniger LJ; Oude Elferink RP; Beuers U
Clin Pharmacol Ther; 2012 Sep; 92(3):381-7. PubMed ID: 22850600
[TBL] [Abstract][Full Text] [Related]
10. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis.
Wagner M; Zollner G; Trauner M
Semin Liver Dis; 2010 May; 30(2):160-77. PubMed ID: 20422498
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptors in acute and chronic cholestasis.
Gonzalez-Sanchez E; Firrincieli D; Housset C; Chignard N
Dig Dis; 2015; 33(3):357-66. PubMed ID: 26045270
[TBL] [Abstract][Full Text] [Related]
12. Role of farnesoid X receptor in cholestasis.
Yuan ZQ; Li KW
J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
[TBL] [Abstract][Full Text] [Related]
13. New molecular insights into the mechanisms of cholestasis.
Wagner M; Zollner G; Trauner M
J Hepatol; 2009 Sep; 51(3):565-80. PubMed ID: 19595470
[TBL] [Abstract][Full Text] [Related]
14. Nuclear receptors, bile-acid detoxification, and cholestasis.
Chen J; Raymond K
Lancet; 2006 Feb; 367(9509):454-6. PubMed ID: 16473109
[No Abstract] [Full Text] [Related]
15. Nuclear receptors as drug targets in cholestatic liver diseases.
Halilbasic E; Baghdasaryan A; Trauner M
Clin Liver Dis; 2013 May; 17(2):161-89. PubMed ID: 23540496
[TBL] [Abstract][Full Text] [Related]
16. Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis.
Stahl S; Davies MR; Cook DI; Graham MJ
Xenobiotica; 2008 Jul; 38(7-8):725-77. PubMed ID: 18668429
[TBL] [Abstract][Full Text] [Related]
17. Organic anion transporting polypeptides, cholestasis, and nuclear receptors.
Kullak-Ublick GA; Jung D; Hagenbuch B; Meier PJ
Hepatology; 2002 Mar; 35(3):732-4. PubMed ID: 11870396
[No Abstract] [Full Text] [Related]
18. Nuclear receptors as new perspective for the management of liver diseases.
Trauner M; Halilbasic E
Gastroenterology; 2011 Apr; 140(4):1120-1125.e1-12. PubMed ID: 21334334
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity.
Zollner G; Wagner M; Trauner M
Pharmacol Ther; 2010 Jun; 126(3):228-43. PubMed ID: 20388526
[TBL] [Abstract][Full Text] [Related]
20. Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1.
Liu X; Xue R; Yang C; Gu J; Chen S; Zhang S
J Biol Chem; 2018 Aug; 293(33):12759-12769. PubMed ID: 29929982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
